Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland

Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland

Background: Pirfenidone and nintedanib are considered as the standard of care in idiopathic pulmonary fibrosis (IPF), but there is no consensus as to which of these two agents should be regarded as first-line treatment. Objective: To provide real-world data on therapeutic decisions of pulmonary spec...

Full description

Bibliographic Details
Main Authors: Katarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś, Adam Białas, Adam Barczyk, Hanna Jagielska-Len, Ewa Jassem, Aleksander Kania, Katarzyna Lewandowska, Sebastian Majewski, Magdalena M. Martusewicz-Boros, Wojciech J. Piotrowski, Alicja Siemińska, Krzysztof Sładek, Małgorzata Sobiecka, Marzena Trzaska-Sobczak, Witold Tomkowski, Beata Żołnowska, Rafał Krenke
Format: Article
Language:English
Published: SAGE Publishing 2022-08-01
Series:Therapeutic Advances in Chronic Disease
Online Access:https://doi.org/10.1177/20406223221117982

Internet

https://doi.org/10.1177/20406223221117982

Similar Items